Rhinology

Rhinology is the bimonthly journal of the International Rhinologic Society and the European Rhinologic Society, founded in 1963 and edited from Amsterdam, covering the nose and paranasal sinuses, with a 2025 Journal Impact Factor of 5.7.《鼻科学》（Rhinology）为（International Rhinologic Society）与（European Rhinologic Society）的双月刊，1963 年创刊，编辑部设在阿姆斯特丹，研究鼻与鼻窦，2025 年期刊影响因子为 5.7。

Scope

• The journal covers the physiology and pathophysiology of the nose and paranasal sinuses.期刊覆盖鼻与鼻窦的生理学与病理生理学。
• Diagnostics are treated broadly, from endoscopy and imaging to objective tests of nasal function and olfaction.诊断内容涵盖内镜、影像，以及鼻功能与嗅觉的客观检测。
• Medical therapy, including pharmacotherapy and allergen immunotherapy, is a major strand.药物治疗，包括药物疗法与过敏原免疫治疗，是主要方向之一。
• Surgical treatment of the nose, sinuses and anterior skull base is covered alongside outcomes and complication research.鼻、鼻窦与前颅底的外科治疗，连同疗效与并发症研究一并覆盖。
• Immunology and allergology are treated as integral to rhinology rather than as adjacent specialties.免疫学与变态反应学被视为鼻科学的组成部分，而非邻近专科。
• Original research, review articles and short communications are published, but case reports are not accepted.期刊发表原创研究、综述与短篇通讯，但不接受病例报告。
• Studies too long for a regular issue may appear as supplements, which are not peer reviewed.篇幅过长、无法纳入常规期次的研究可作为增刊发表，增刊不经过同行评审。

History

• The journal was founded in 1963 by H.A.E. van Dishoeck, an early Dutch rhinologist based in Leiden.本刊于 1963 年由荷兰鼻科学先驱（H.A.E. van Dishoeck）创办。
• It has always been a non-profit publication owned by the societies rather than by a commercial publisher.期刊始终是由学会拥有、而非商业出版社拥有的非营利出版物。
• It is the official organ of both the European Rhinologic Society and the International Rhinologic Society.本刊同时是（European Rhinologic Society）与（International Rhinologic Society）的官方刊物。
• Six issues appear each year, in February, April, June, August, October and December.每年出版六期，分别在二月、四月、六月、八月、十月与十二月出刊。
• A supplement series runs alongside the journal, reaching supplement 35 in 2025.期刊另设增刊系列，至 2025 年已出至第 35 号增刊。
• The 2025 Journal Impact Factor is 5.7, after 6.8 in 2024, 6.634 in 2022 and 3.681 in 2021, and it ranks 2nd of 67 titles in otorhinolaryngology.2025 年期刊影响因子为 5.7，2024 年为 6.8，2022 年为 6.634，2021 年为 3.681，在耳鼻咽喉科学类 67 种期刊中位列第 2。

Editors

• Wytske J. Fokkens, an otorhinolaryngologist and clinical epidemiologist at Amsterdam University Medical Centre, is editor-in-chief.阿姆斯特丹大学医学中心的耳鼻咽喉科医师兼临床流行病学家 Wytske J. Fokkens 担任主编。
• Wilfred T.V. Germeraad, an immunologist at Maastricht University Medical Centre, is managing editor.马斯特里赫特大学医学中心的免疫学家 Wilfred T.V. Germeraad 担任执行编辑。
• Five associate editors handle submissions: Basile Landis in Geneva, Sietze Reitsma in Amsterdam, Sanna Toppila-Salmi in Helsinki, Ahmad Sedaghat in Cincinnati and Michael Soyka in Zurich.五位副编辑负责稿件：日内瓦的 Basile Landis、阿姆斯特丹的 Sietze Reitsma、赫尔辛基的 Sanna Toppila-Salmi、辛辛那提的 Ahmad Sedaghat 与苏黎世的 Michael Soyka。
• Egbert Huizing and Valerie Lund hold the title of honorary editor.Egbert Huizing 与 Valerie Lund 获授荣誉编辑称号。
• The editorial board numbers about thirty-five, drawn from Europe, North America, Asia and Australia.编委会约三十五人，来自欧洲、北美、亚洲与澳大利亚。
• All papers are peer reviewed, while letters to the editor are not revised beyond correction of English.所有论文均经同行评审，而致编辑的信仅作英文校正，不作内容修改。